Immediate Impact
51 standout
Citing Papers
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
2022 Standout
Layered double hydroxide-based nanomaterials for biomedical applications
2022 Standout
Works of Laura Lozza being referenced
Radiotherapy with the anti-programmed cell death ligand-1 immune checkpoint blocker avelumab: acute toxicities in triple-negative breast cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Laura Lozza | 705 | 1312 | 1035 | 2073 | 77 | 3.5k | |
| Salvatore Lo Vullo | 612 | 2243 | 1382 | 2321 | 79 | 4.8k | |
| M. Salzer‐Kuntschik | 588 | 1329 | 1218 | 3760 | 68 | 4.8k | |
| Dominique Ranchère‐Vince | 364 | 1374 | 507 | 2906 | 87 | 3.8k | |
| Ernest U. Conrad | 399 | 876 | 675 | 2434 | 98 | 4.1k | |
| Richard B. Womer | 526 | 1533 | 1113 | 3734 | 111 | 5.9k | |
| Janusz Limon | 954 | 1154 | 1033 | 2519 | 233 | 5.7k | |
| Patrizia Olmi | 195 | 1804 | 1204 | 2609 | 70 | 4.7k | |
| Richard G. Martin | 623 | 2098 | 938 | 2281 | 56 | 3.8k | |
| Ivy A. Petersen | 606 | 1638 | 1669 | 1708 | 144 | 4.5k | |
| Ewa Kościelniak | 290 | 1287 | 976 | 2806 | 165 | 4.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...